The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
- 18 May 2009
- journal article
- review article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 87 (1) , 1-11
- https://doi.org/10.1016/j.yexmp.2009.05.001
Abstract
No abstract availableKeywords
This publication has 231 references indexed in Scilit:
- Systemic Spread Is an Early Step in Breast CancerCancer Cell, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancerCancer Cell, 2005
- Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor inductionCancer Cell, 2004
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- Metastasis genes: A progression puzzleNature, 2002
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The Hallmarks of CancerCell, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997